Corient Capital Partners’s Patterson-UTI PTEN Stock Holding History

Corient Capital Partners’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$190K	Hold	12,031	–	–	0.01%	619
2022 Q2	$190K	Sell	12,031 -257	-2%	-$4.32K	0.01%	635
2022 Q1	$190K	Buy	12,288 +1,691	+16%	+$21.3K	0.01%	691
2021 Q4	$90K	Sell	10,597 -356	-3%	-$3.07K	0.01%	702
2021 Q3	$99K	Buy	10,953 +651	+6%	+$5.27K	0.01%	678
2021 Q2	$102K	Sell	10,302 -917	-8%	-$7.76K	0.01%	666
2021 Q1	$80K	Buy	11,219 +798	+8%	+$5.62K	0.01%	604
2020 Q4	$55K	Buy	10,421 +305	+3%	+$1.2K	0.01%	527
2020 Q3	$29K	Sell	10,116 -960	-9%	-$3.53K	﹤0.01%	508
2020 Q2	$38K	Sell	11,076 -8,079	-42%	-$27.9K	﹤0.01%	490
2020 Q1	$45K	Buy	+19,155	New	+$124K	0.01%	394

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Anomaly Capital Management New York $1.65B AUM 26.47% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Corient Capital Partners's PTEN Position: Q3 2022 in Review

Corient Capital Partners held its Patterson-UTI (PTEN) position steady in Q3 2022 at 12,031 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #619.

Corient Capital Partners first reported a position in PTEN in Q1 2020 and has held it in 11 quarters since. 285 funds tracked by Wall St. Rank hold PTEN as of Q3 2022.

Corient Capital Partners held 12,031 shares of Patterson-UTI worth $190K as of Q3 2022.
Corient Capital Partners left its Patterson-UTI share count unchanged in Q3 2022.
Patterson-UTI made up 0.01% of Corient Capital Partners's portfolio in Q3 2022, its #619 holding.
Corient Capital Partners first reported a position in Patterson-UTI in Q1 2020 and has held it in 11 quarters since.
285 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.